Skip to main content
Premium Trial:

Request an Annual Quote

Israeli Personalized Medicine Center Gets $50M Donation

NEW YORK (GenomeWeb News) – The Weizmann Institute of Science has received a $50 million donation to fund operations at the new Israel National Center for Personalized Medicine (INCPM), which is located at the Weizmann campus in Rehovot, Israel.

The INCPM is focused on conducting research involving genomics, protein profiling, bioinformatics, and drug discovery to advance new personalized approaches to diagnosing, treating, and preventing diseases.

The American Committee for the Weizmann Institute of Science said today that Nancy and Stephen Grand committed the funding, and that the INCPM has incorporated the Grand name into its own.

Now named the Nancy and Stephen Grand INCPM, the center is a national consortium that serves Israel's life sciences research community, hospitals, and industry. It will engage in international collaborations and "[draw] upon Israel's diverse genetic pool comprised of populations from around the globe," the committee said.

The institute is composed of the Crown Institute for Genomics; the de Botton Institute for Protein Profiling; the Wohl Institute for Drug Discovery; and the Mantoux Bioinformatics Institute.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.